Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

uled Financial Results Call Arena will host a conference call and webcast to discuss the third quarter 2011 financial results and to provide a business and financial update tomorrow, November 10, 2011, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).

The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Third Quarter 2011 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

Upcoming Corporate PresentationsArena is planning to present at upcoming investment and industry conferences, including:

  • Piper Jaffray 23rd Annual Health Care Conference, November 29-30, 2011, New York, New York
  • 30th Annual J.P. Morgan Healthcare Conference, January 9-12, 2012, San Francisco, California

  • About LorcaserinLorcaserin is an investigational drug candidate intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (BMI greater than or equal to 30) or patients who are overweight (BMI greater than or equal to 27) and have at least one weight-related co-morbid condition. Lorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area believed to be involved in the control of appetite and metabolism. Arena has patents that cover lorcaserin in the United States and other jurisdictions that in most cases are capable of continuing into 2023 without taking into acco
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
    3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
    4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
    5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
    6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
    7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
    8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
    9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
    10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
    11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... DALLAS , Sept. 19, 2014 /PRNewswire-iReach/ ... Chinese Oxybutynin Hydrochloride Industry, 2009-2019 is a ... and Chinese Oxybutynin Hydrochloride industry. The report ... Hydrochloride including its classification, application and manufacturing ... China,s top manufacturers of Oxybutynin Hydrochloride listing ...
    (Date:9/19/2014)...  The board of directors of AbbVie Inc. (NYSE: ... of $0.42 per share.  The cash ... record at the close of business on Oct. 15, ... research-based biopharmaceutical company formed in 2013 following separation from ... dedicated people and unique approach to innovation to develop ...
    (Date:9/19/2014)... -- Merck (NYSE: MRK ), known as MSD outside ... , is teaming with celebrity chef and cookbook author Leticia ... an educational program encouraging Hispanics with type 2 diabetes to achieve ... to help reduce the risk of serious health problems. Hispanics in ... risk for developing type 2 diabetes than non-Hispanic white adults, and ...
    Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
    ... (vRad), a technology-enabled national radiology practice, announced ... Radiology Associates (MRA) have joined its Pennsylvania-based ... (DII). These former MRA radiologists will continue ... and join the more than 60 DII ...
    ... 2011  The Austen BioInnovation Institute in Akron (ABIA) ... today a strategic partnership to share expertise while ... The partnership combines the polymer ... of ABIA with Lubrizol, a key medical polymer ...
    Cached Medicine Technology:vRad Radiology Alliance Continues to Transform Radiology With Most Recent Practice Partnership 2Austen BioInnovation Institute and Lubrizol Announce New Strategic Innovation Partnership 2Austen BioInnovation Institute and Lubrizol Announce New Strategic Innovation Partnership 3
    (Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
    (Date:9/21/2014)... California (PRWEB) September 21, 2014 According to ... experienced the highest birth rate since 1966 (10.5 births per ... in their early 40s has risen steadily by 2 percent ... includes births to women aged 50 and over) also rose, ... that there were more than nine times as many first ...
    (Date:9/20/2014)... 2014 Weight Destroyer , a ... expert Michael Wren that has already helped tens of ... health conditions like high blood pressure, high cholesterol, and ... prompting an investigative review. , “Weight Destroyer is ... down by showing people what is truly effective when ...
    (Date:9/20/2014)... (PRWEB) September 21, 2014 Increases ... contributing to greater waste treatment volumes. However, government ... diverting waste from landfill. According to IBISWorld industry ... have implemented strategies aimed at reducing the volume ... waste recycled and recovered.” Still, a large proportion ...
    (Date:9/20/2014)... The print component of “Work-Life ... the Calgary Herald, with a circulation of approximately ... The digital component is distributed nationally through a ... of top news sites and partner outlets. To ... http://www.worklifebalanceinfo.ca . , The publication features an ...
    Breaking Medicine News(10 mins):Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2
    ... HealthDay Reporter , TUESDAY, Nov. 22 (HealthDay News) -- The ... will pay $950 million to resolve investigations into its marketing ... market in 2004 after studies revealed the drug increased users, ... pay $321.6 million in criminal fines and $628.4 million as ...
    ... July change the country? That question has been put to ... "Norwegians are still in a state of shock," says professor ... that people need time to come to terms with them." ... will give to promises made about more openness and democracy ...
    ... Serena Gordon HealthDay Reporter , TUESDAY, Nov. ... for anyone taking the cholesterol-lowering medications known as statins: ... for long periods of time, they say. ... reduced the risk of cardiovascular disease by almost one-quarter. ...
    ... decades ago, sudden cardiac arrest was a death sentence. Today, ... every six hours in Sweden, reveals a thesis from the ... cases of sudden cardiac arrest over a 30-year period. ... of victims of sudden cardiac arrest, shows a thesis from ...
    ... as the most malignant form of brain tumor. In many ... because of the risk of destroying too much brain tissue ... all the fine extensions by which the tumor spreads into ... of tumor cells that have remained in the head, almost ...
    ... Amanda Gardner HealthDay Reporter , TUESDAY, Nov. 22 (HealthDay ... salt may harbor almost as much danger as too much salt, ... consuming more than 6,000 or 7,000 milligrams of sodium per day, ... Nov. 23/30 issue of the Journal of the American Medical ...
    Cached Medicine News:Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 2Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 3Health News:Coming to terms with terror 2Health News:Coming to terms with terror 3Health News:Coming to terms with terror 4Health News:Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds 2Health News:Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds 3Health News:Sharp decrease in deaths from sudden cardiac arrest 2Health News:Enhanced treatment of brain tumors 2Health News:How Much Salt Is Best for the Heart? 2Health News:How Much Salt Is Best for the Heart? 3
    ... Infinity™ ALT single liquid stable reagent ... quantitative determination of ALT in serum. ... not only provides excellent stability and ... correlation against existing assays. The reagent ...
    ... The Konelab 20XT analyzer is the ... clinical chemistry analyzers and reagents, designed to ... routine and specialty clinical laboratories. The Konelab ... as Konelab 20 and yet improves on ...
    ... works hand in hand with the Sequenza ... method for immunostaining. The Sequenza Immunostaining center ... consistency and excellent staining quality. Allows the ... to 50 slides/run) with a low chance ...
    ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
    Medicine Products: